Denosumab Sequential Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

July 1, 2023

Study Completion Date

December 31, 2023

Conditions
Osteoporosis
Interventions
DRUG

Zoledronic Acid

Use Zoledronic acid as a sequential therapy after denosumab treatment for more than 2 years

DRUG

Denosumab

Continuous Denosumab treatment in arm 1 for two years or as a 2nd year treatment in arm 2 for one year

Trial Locations (1)

64041

Department of Orthopedics, National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT03868033 - Denosumab Sequential Therapy | Biotech Hunter | Biotech Hunter